The high-density lipoprotein-adjusted SCORE model worsens SCORE-based risk classification in a contemporary population of 30,824 Europeans: the Copenhagen General Population Study

Medicin og biovidenskab

• HDL Lipoproteins 100%
• Cardiovascular Diseases 68%
• Population 37%
• Guidelines 13%
• Morbidity 12%
• Health Services Needs and Demand 11%
• Primary Prevention 10%
• Hydroxymethylglutaryl-CoA Reductase Inhibitors 10%
• HDL Cholesterol 9%
• Risk Assessment 8%
• Mortality 5%